FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 352:2314-2324 June 2, 2005 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.

A 10-year-old girl with atopic dermatitis reports itching that has recently become relentless, resulting in sleep loss. Her mother has been reluctant to treat the girl with topical corticosteroids, because she was told that they damage the skin, but she is exhausted and wants relief for her child. How should the problem be managed?

The Clinical Problem

Atopic dermatitis (or atopic eczema) is an itchy, . . . [Full Text of this Article]

Diagnostic Criteria

Prevalence, Cost, and Prognosis

Causes

Strategies and Evidence

Diagnosis

Treatment

            Topical Corticosteroids

            Emollients

            Topical Calcineurin Inhibitors

            Other Topical Agents

            Oral Antihistamines

            Topical Doxepin

            Antibiotic Agents

            Ultraviolet Light

            Immunosuppressive Agents

            Nonpharmacologic Approaches

Areas of Uncertainty

Guidelines

Conclusions and Recommendations

Source Information

From the Center of Evidence-Based Dermatology, Queen's Medical Center, University of Nottingham, Nottingham, United Kingdom.

Address reprint requests to Professor Williams at the Center of Evidence-Based Dermatology, Queen's Medical Center, University of Nottingham, Nottingham NG7 2UH, United Kingdom, or at hywel.williams@nottingham.ac.uk.

Related Letters:

Atopic Dermatitis
Treloar V., Williams H. C.
Extract | Full Text | PDF  
N Engl J Med 2005; 353:1069-1070, Sep 8, 2005. Correspondence

This article has been cited by other articles:

• Kato, A., Chustz, R. T., Ogasawara, T., Kulka, M., Saito, H., Schleimer, R. P., Matsumoto, K. (2009). Dexamethasone and FK506 Inhibit Expression of Distinct Subsets of Chemokines in Human Mast Cells. J. Immunol. 182: 7233-7243 [Abstract] [Full Text]  
• Schmitt, J., Romanos, M., Schmitt, N. M., Meurer, M., Kirch, W. (2009). Atopic Eczema and Attention-Deficit/Hyperactivity Disorder in a Population-Based Sample of Children and Adolescents. JAMA 301: 724-726 [Full Text]  
• Muller, M., Essin, K., Hill, K., Beschmann, H., Rubant, S., Schempp, C. M., Gollasch, M., Boehncke, W. H., Harteneck, C., Muller, W. E., Leuner, K. (2008). Specific TRPC6 Channel Activation, a Novel Approach to Stimulate Keratinocyte Differentiation. J. Biol. Chem. 283: 33942-33954 [Abstract] [Full Text]  
• Krakowski, A. C., Eichenfield, L. F., Dohil, M. A. (2008). Management of Atopic Dermatitis in the Pediatric Population. Pediatrics 122: 812-824 [Abstract] [Full Text]  
• Williams, H. C (2007). Established corticosteroid creams should be applied only once daily in patients with atopic eczema. BMJ 334: 1272-1272 [Full Text]  
• Lio, P. A (2007). Atopic dermatitis and food allergies: true, true and related?. EDUCATION AND PRACTICE 92: ep56-ep60 [Full Text]  
• Williams, H. C. (2006). Two "positive" studies of probiotics for atopic dermatitis: or are they?. Arch Dermatol 142: 1201-1203 [Full Text]  
• Brown, S., Reynolds, N. J (2006). Atopic and non-atopic eczema. BMJ 332: 584-588 [Full Text]  
• Treloar, V., Williams, H. C. (2005). Atopic Dermatitis. NEJM 353: 1069-1070 [Full Text]